Regulation of histone H3K4 methylation in brain development and disease

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 369, Issue 1652, 2014, Pages

  Shen, Erica ^a   Shulha, Hennady ^b   Weng, Zhiping ^b   Akbarian, Schahram ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autism; Chromatin; Epigenetic; Histone; Nucleosome; Schizophrenia

Indexed keywords

BRAIN; DISEASE; GENE EXPRESSION; GENOME; METHYLATION; MUTATION; PARENTAL CARE;

HISTONE; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE;

ANIMAL; AUTISM; BRAIN; GENETIC EPIGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHYLATION; MOUSE; MUTATION; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHIZOPHRENIA;

ANIMALS; AUTISTIC DISORDER; BRAIN; EPIGENESIS, GENETIC; HISTONE DEMETHYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; METHYLATION; MICE; MUTATION; NERVOUS SYSTEM DISEASES; SCHIZOPHRENIA;

EID: 84906086344     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2013.0514     Document Type: Review

References (107)

1. Numata S et al. 2012 DNA methylation signatures in development and aging of the human prefrontal cortex. Am. J. Hum. Genet. 90, 260-272. (doi:10. 1016/j.ajhg.2011.12.020)
2. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, Jaenisch R, Laird PW, Akbarian S. 2007 DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2, e895. (doi:10.1371/journal. pone.0000895)
3. Hernandez DG et al. 2011 Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum. Mol. Genet. 20, 1164-1172. (doi:10.1093/hmg/ddq561)
4. Cheung I, Shulha HP, Jiang Y, Matevossian A, Wang J, Weng Z, Akbarian S. 2010 Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc. Natl Acad. Sci. USA 107, 8824-8829. (doi:10.1073/ pnas.1001702107)
5. Ronan JL, Wu W, Crabtree GR. 2013 From neural development to cognition: unexpected roles for chromatin. Nat. Rev. Genet. 14, 347-359. (doi:10. 1038/nrg3413)
6. Klein CJ et al. 2011 Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat. Genet. 43, 595-600. (doi:10. 1038/ng.830)
7. Winkelmann J et al. 2012 Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum. Mol. Genet. 21, 2205-2210. (doi:10.1093/hmg/dds035)
8. Jakovcevski M, Akbarian S. 2012 Epigenetic mechanisms in neurological disease. Nat. Med. 18, 1194-1204. (doi:10.1038/nm.2828)
9. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007 Highresolution profiling of histone methylations in the human genome. Cell 129, 823-837. (doi:10.1016/j. cell.2007.05.009)
10. Shulha HP, Cheung I, Guo Y, Akbarian S, Weng Z. 2013 Coordinated cell type-specific epigenetic remodeling in prefrontal cortex begins before birth and continues into early adulthood. PLoS Genet. 9, e1003433. (doi:10.1371/journal.pgen. 1003433)
11. Shulha HP et al. 2012 Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch. Gen. Psychiatry 69, 314-324. (doi:10.1001/archgenpsychiatry.2011.151)
12. Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S. 2007 Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J. Neurosci. 27, 11 254-11 262. (doi:10.1523/ JNEUROSCI.3272-07.2007)
13. Kouzarides T. 2007 Chromatin modifications and their function. Cell 128, 693-705. (doi:10.1016/j. cell.2007.02.005)
14. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. 2007 How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14, 1025-40. (doi:10.1038/nsmb1338)
15. Tan M et al. 2011 Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1016-1028. (doi:10. 1016/j.cell.2011.08.008)
16. Zhou VW, Goren A, Bernstein BE. 2011 Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 12, 7-18. (doi:10.1038/nrg2905)
17. Shulha HP et al. 2012 Human-specific histone methylation signatures at transcription start sites in prefrontal neurons. PLoS Biol. 10, e1001427. (doi:10.1371/journal.pbio.1001427)
18. Barrera LO, Li Z, Smith AD, Arden KC, Cavenee WK, Zhang MQ, Green RD, Ren B. 2008 Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs. Genome Res. 18, 46-59. (doi:10.1101/gr.6654808)
19. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. 2007 A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 77-88. (doi:10.1016/j.cell.2007.05.042)
20. Guenther MG, Jenner RG, Chevalier B, Nakamura T, Croce CM, Canaani E, Young RA. 2005 Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl Acad. Sci. USA 102, 8603-8608. (doi:10. 1073/pnas.0503072102)
21. Shilatifard A. 2008 Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 20, 341-348. (doi:10.1016/j.ceb.2008.03.019)
22. Shilatifard A. 2012 The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu. Rev. Biochem. 81, 65-95. (doi:10.1146/annurevbiochem-051710-134100)
23. Maston GA, Landt SG, Snyder M, Green MR. 2012 Characterization of enhancer function from genomewide analyses. Annu. Rev. Genom. Hum. Genet. 13, 29-57. (doi:10.1146/annurev-genom-090711-163723)
24. Creyghton MP et al. 2010 Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21 931-21 936. (doi:10.1073/pnas.1016071107)
25. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011 A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283. (doi:10.1038/ nature09692)
26. Zhu J et al. 2013 Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152, 642-654. (doi:10. 1016/j.cell.2012.12.033)
27. Hu JL, Zhou BO, Zhang RR, Zhang KL, Zhou JQ, Xu GL. 2009 The N-terminus of histone H3 is required for de novo DNA methylation in chromatin. Proc. Natl Acad. Sci. USA 106, 22 187-22 192. (doi:10. 1073/pnas.0905767106)
28. Ooi SK et al. 2007 DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448, 714-717. (doi:10.1038/ nature05987)
29. Black JC, Van Rechem C, Whetstine JR. 2012 Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell 48, 491-507. (doi:10.1016/j.molcel.2012.11.006)
30. Ernst P, Vakoc CR. 2012 WRAD: enabler of the SET1-family of H3K4 methyltransferases. Brief. Funct. Genomics 11, 217-226. (doi:10.1093/bfgp/els017)
31. Peter CJ, Akbarian S. 2011 Balancing histone methylation activities in psychiatric disorders. Trends Mol. Med. 17, 372-379. (doi:10.1016/j.molmed. 2011.02.003)
32. Rincon-Arano H, Halow J, Delrow JJ, Parkhurst SM, Groudine M. 2012 UpSET recruits HDAC complexes and restricts chromatin accessibility and acetylation at promoter regions. Cell 151, 1214-1228. (doi:10. 1016/j.cell.2012.11.009)
33. Sebastian S, Sreenivas P, Sambasivan R, Cheedipudi S, Kandalla P, Pavlath GK, Dhawan J. 2009 MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation. Proc. Natl Acad. Sci. USA 106, 4719-4724. (doi:10.1073/pnas. 0807136106)
34. Del Rizzo PA, Trievel RC. 2011 Substrate and product specificities of SET domain methyltransferases. Epigenetics 6, 1059-1067. (doi:10.4161/epi.6.9. 16069)
35. Agarwal SK, Jothi R. 2012 Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors. PLoS ONE 7, e37952. (doi:10.1371/journal.pone.0037952)
36. Huang J, Gurung B, Wan B, Matkar S, Veniaminova NA, Wan K, Merchant JL, Hua X, Lei M. 2012 The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482, 542-546. (doi:10.1038/nature10806)
37. Wang P et al. 2009 Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell. Biol. 29, 6074-6085. (doi:10.1128/MCB.00924-09)
38. Katada S, Sassone-Corsi P. 2010 The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. Nat. Struct. Mol. Biol. 17, 1414-1421. (doi:10.1038/nsmb.1961)
39. Lim DA, Huang YC, Swigut T, Mirick AL, Garcia-Verdugo JM, Wysocka J, Ernst P, Alvarez-Buylla A. 2009 Chromatin remodelling factor Mll1 is essential for neurogenesis from postnatal neural stem cells. Nature 458, 529-533. (doi:10.1038/nature07726)
40. Wu M, Wang PF, Lee JS, Martin-Brown S, Florens L, Washburn M, Shilatifard A. 2008 Molecular regulation of H3K4 trimethylation by Wdr82, a component of human Set1/COMPASS. Mol. Cell. Biol. 28, 7337-7344. (doi:10.1128/MCB.00976-08)
41. van Nuland R, Smits AH, Pallaki P, Jansen PW, Vermeulen M, Timmers HT. 2013 Quantitative dissection and stoichiometry determination of the human SET1/MLL histone methyltransferase complexes. Mol. Cell. Biol. 33, 2067-2077. (doi:10. 1128/MCB.01742-12)
42. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T. 2009 KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461, 415-418. (doi:10. 1038/nature08315)
43. Ruthenburg AJ, Allis CD, Wysocka J. 2007 Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 25, 15-30. (doi:10.1016/j.molcel.2006.12.014)
44. Mosammaparast N, Shi Y. 2010 Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155-179. (doi:10.1146/annurev. biochem.78.070907.103946)
45. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Günther T, Buettner R, Schüle R. 2005 LSD1 demethylates repressive histone marks to promote androgenreceptor-dependent transcription. Nature 437, 436-439.
46. Selvi BR, Mohankrishna DV, Ostwal YB, Kundu TK. 2010 Small molecule modulators of histone acetylation and methylation: a disease perspective. Biochim. Biophys. Acta 1799, 810-828. (doi:10. 1016/j.bbagrm.2010.09.005)
47. Fang R et al. 2010 Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol. Cell 39, 222-233. (doi:10.1016/j.molcel.2010.07.008)
48. Hannibal MC et al. 2011 Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am. J. Med. Genet. A 155, 1511-1516. (doi:10. 1002/ajmg.a.34074)
49. Ng SB et al. 2010 Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42, 790-793. (doi:10.1038/ng.646)
50. Banka S et al. 2013 MLL2 mosaic mutations and intragenic deletion-duplications in patients with Kabuki syndrome. Clin. Genet. 83, 467-471. (doi:10.1111/j.1399-0004.2012.01955.x)
51. Jones WD et al. 2012 De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am. J. Hum. Genet. 91, 358-364. (doi:10.1016/j.ajhg. 2012.06.008)
52. Kleefstra T et al. 2012 Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am. J. Hum. Genet. 91, 73-82. (doi:10.1016/j.ajhg.2012.05.003)
53. Isidor B, Pichon O, Baron S, David A, Le Caignec C. 2010 Deletion of the CUL4B gene in a boy with mental retardation, minor facial anomalies, short stature, hypogonadism, and ataxia. Am. J. Med. Genet. A 152, 175-180. (doi:10.1002/ajmg.a. 33152)
54. Badura-Stronka M, Jamsheer A, Materna-Kiryluk A, Sowinska A, Kiryluk K, Budny B, Latos-Bieleńska A. 2010 A novel nonsense mutation in CUL4B gene in three brothers with X-linked mental retardation syndrome. Clin. Genet. 77, 141-144. (doi:10.1111/j. 1399-0004.2009.01331.x)
55. Tarpey PS et al. 2007 Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an Xlinked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 80, 345-352. (doi:10.1086/511134)
56. Nakagawa T, Xiong Y. 2011 X-linked mental retardation gene CUL4B targets ubiquitylation of H3K4 methyltransferase component WDR5 and regulates neuronal gene expression. Molecular Cell 43, 381-391. (doi:10.1016/j.molcel.2011.05.033)
57. Najmabadi H et al. 2011 Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478, 57-63. (doi:10.1038/nature10423)
58. Adegbola A, Gao H, Sommer S, Browning M. 2008 A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am. J. Med. Genet. A 146, 505-511. (doi:10.1002/ajmg.a.32142)
59. Iwase S et al. 2007 The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088. (doi:10.1016/j.cell.2007.02.017)
60. Abidi FE, Holloway L, Moore CA, Weaver DD, Simensen RJ, Stevenson RE, Rogers RC, Schwartz CE. 2008 Mutations in JARID1C are associated with Xlinked mental retardation, short stature and hyperreflexia. J. Med. Genet. 45, 787-793. (doi:10. 1136/jmg.2008.058990)
61. Poeta L et al. 2013 A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX. Am. J. Hum. Genet. 92, 114-125. (doi:10.1016/j. ajhg.2012.11.008)
62. Neale BM et al. 2012 Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245. (doi:10.1038/nature11011)
63. O'Roak BJ et al. 2012 Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250. (doi:10.1038/ nature10989)
64. Banka S et al. 2012 How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur. J. Hum. Genet. 20, 381-388. (doi:10.1038/ejhg.2011.220)
65. Li Y et al. 2011 A mutation screen in patients with Kabuki syndrome. Hum. Genet. 130, 715-724. (doi:10.1007/s00439-011-1004-y)
66. Jensen LR et al. 2005 Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76, 227-236. (doi:10.1086/427563)
67. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y. 2007 The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447, 601-605. (doi:10.1038/nature05823)
68. Bienvenu T et al. 2002 ARX, a novel Prd-classhomeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum. Mol. Genet. 11, 981-991. (doi:10.1093/hmg/11.8.981)
69. Grønskov K, Hjalgrim H, Nielsen IM, Brøndum-Nielsen K. 2004 Screening of the ARX gene in 682 retarded males. Eur. J. Hum. Genet. 12, 701-705. (doi:10.1038/sj.ejhg.5201222)
70. Kato M et al. 2004 Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation. Hum. Mutat. 23, 147-59. (doi:10.1002/humu.10310)
71. Kato M, Saitoh S, Kamei A, Shiraishi H, Ueda Y, Akasaka M, Hayasaka K. 2007 A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppressionburst pattern (Ohtahara syndrome). Am. J. Hum. Genet. 81, 361-366. (doi:10.1086/518903)
72. Kitamura K et al. 2002 Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32, 359-369. (doi:10.1038/ng1009)
73. Proud VK, Levine C, Carpenter NJ. 1992 New Xlinked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosum. Am. J. Med. Genet. 43, 458-466. (doi:10. 1002/ajmg.1320430169)
74. Strømme P et al. 2002 Mutations in the human ortholog of Aristaless cause X linked mental retardation and epilepsy. Nat. Genet. 30, 441-445. (doi:10.1038/ng862)
75. Cabezas DA, Slaugh R, Abidi F, Arena JF, Stevenson RE, Schwartz CE, Lubs HA. 2000 A new X linked mental retardation (XLMR) syndrome with short stature, small testes, muscle wasting, and tremor localises to Xq24-q25. J. Med. Genet. 37, 663-668. (doi:10.1136/jmg.37.9.663)
76. Ravn K, Lindquist SG, Nielsen K, Dahm TL, Tümer Z. 2012 Deletion of CUL4B leads to concordant phenotype in a monozygotic twin pair. Clin. Genet. 82, 292-294. (doi:10.1111/j.1399-0004.2011. 01839.x)
77. Tarpey PS et al. 2009 A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat. Genet. 41, 535-543. (doi:10.1038/ng.367)
78. Zou Y et al. 2007 Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am. J. Hum. Genet. 80, 561-566. (doi:10.1086/ 512489)
79. Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD, Paylor RE, Lubin FD. 2010 Histone methylation regulates memory formation. J. Neurosci. 30, 3589-3599. (doi:10.1523/ JNEUROSCI.3732-09.2010)
80. Kim SY, Levenson JM, Korsmeyer S, Sweatt JD, Schumacher A. 2007 Developmental regulation of Eed complex composition governs a switch in global histone modification in brain. J. Biol. Chem. 282, 9962-9972. (doi:10.1074/jbc.M608722200)
81. Ansari KI, Mandal SS. 2010 Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J. 277, 1790-1804. (doi:10.1111/j.1742-4658.2010.07606.x)
82. Kerimoglu C et al. 2013 Histone-methyltransferase MLL2 (KMT2B) is required for memory formation in mice. J. Neurosci. 33, 3452-3464. (doi:10.1523/ JNEUROSCI.3356-12.2013)
83. Marsh E et al. 2009 Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 132, 1563-1576. (doi:10.1093/ brain/awp107)
84. Christensen D et al. 2013 Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning: autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev. Med. Child Neurol. 56, 59-65. (doi:10.1111/ dmcn.12268)
85. Ibrahim HM, Tamminga CA. 2010 Schizophrenia: treatment targets beyond monoamine systems. Annu. Rev. Pharmacol. Toxicol. 51, 189-209. (doi:10.1146/annurev.pharmtox.010909.105851)
86. Kenny EM et al. 2013 Excess of rare novel loss-offunction variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry epub ahead of print. (doi:10.1038/mp.2013.127)
87. Murdoch JD, State MW. 2013 Recent developments in the genetics of autism spectrum disorders. Curr. Opin. Genet. Dev. 23, 310-315. (doi:10.1016/j.gde. 2013.02.003)
88. Akbarian S, Huang HS. 2006 Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res. Rev. 52, 293-304. (doi:10.1016/j.brainresrev.2006. 04.001)
89. Connor CM, Crawford BC, Akbarian S. 2011 White matter neuron alterations in schizophrenia and related disorders. Int. J. Dev. Neurosci. 29, 325-334. (doi:10.1016/j.ijdevneu.2010.07.236)
90. Bagot RC, Zhang TY, Wen X, Nguyen TT, Nguyen HB, Diorio J, Wong TP, Meaney MJ. 2012 Variations in postnatal maternal care and the epigenetic regulation of metabotropic glutamate receptor 1 expression and hippocampal function in the rat. Proc. Natl Acad. Sci. USA 109(Suppl. 2), 17 200-17 207. (doi:10.1073/pnas.1204599109)
91. Meyer U. 2013 Prenatal poly(I:C) exposure and other developmental immune activation models in rodent systems. Biol. Psychiatry 75, 307-315. (doi:10. 1016/j.biopsych.2013.07.011)
92. Bauman MD, Iosif AM, Smith SE, Bregere C, Amaral DG, Patterson PH. 2013 Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol. Psychiatry 75, 332-341. (doi:10.1016/j.biopsych. 2013.06.025)
93. Connor CM, Dincer A, Straubhaar J, Galler JR, Houston IB, Akbarian S. 2012 Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophr. Res. 140, 175-184. (doi:10. 1016/j.schres.2012.06.037)
94. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. 2006 A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol. Psychiatry 60, 253-264. (doi:10.1016/j.biopsych.2006.01.003)
95. Mackowiak M, Bator E, Latusz J, Mordalska P, Wedzony K. 2013 Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex. Eur. Neuropsychopharmacol. 24, 271-289. (doi:10.1016/ j.euroneuro.2013.05.013)
96. Aguilar-Valles A, Vaissiere T, Griggs EM, Mikaelsson MA, Takacs IF, Young EJ, Rumbaugh G, Miller CA. 2013 Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation. Biol. Psychiatry 76, 57-65. (doi:10.1016/j.biopsych.2013.09.014)
97. Akbarian S et al. 2005 Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 62, 829-840. (doi:10.1001/archpsyc.62.8.829)
98. Kano S et al. 2013 Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia. Mol. Psychiatry 18, 740-742. (doi:10.1038/mp. 2012.120)
99. Cruceanu C, Alda M, Nagy C, Freemantle E, Rouleau GA, Turecki G. 2013 H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Int. J. Neuropsychopharmacol. 16, 289-299. (doi:10.1017/S1461145712000363)
100. Ernst C, Chen ES, Turecki G. 2009 Histone methylation and decreased expression of TrkB. T1 in orbital frontal cortex of suicide completers. Mol. Psychiatry 14, 830-832. (doi:10.1038/mp.2009.35)
101. Morris MJ, Karra AS, Monteggia LM. 2010 Histone deacetylases govern cellular mechanisms underlying behavioral and synaptic plasticity in the developing and adult brain. Behav. Pharmacol. 21, 409-419. (doi:10.1097/FBP.0b013e32833c20c0)
102. Covington 3rd HE et al. 2009 Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 29, 11 451-11 460. (doi:10.1523/JNEUROSCI.1758-09.2009)
103. Schroeder FA, Lin CL, Crusio WE, Akbarian S. 2007 Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol. Psychiatry 62, 55-64. (doi:10.1016/j. biopsych.2006.06.036)
104. Parkel S, Lopez-Atalaya JP, Barco A. 2013 Histone H3 lysine methylation in cognition and intellectual disability disorders. Learn. Mem. 20, 570-579. (doi:10.1101/lm.029363.112)
105. Jarome TJ, Lubin FD. 2013 Histone lysine methylation: critical regulator of memory and behavior. Rev. Neurosci. 24, 375-387. (doi:10. 1515/revneuro-2013-0008)
106. Gilman SR, Chang J, Xu B, Bawa TS, Gogos JA, Karayiorgou M, Vitkup D. 2012 Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat. Neurosci. 15, 1723-1728. (doi:10.1038/ nn.3261)
107. Takata A, Xu B, Ionita-Laza I, Roos JL, Gogos JA, Karayiorgou M. 2014 Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Neuron 82, 773-780. (doi:10. 1016/j.neuron.2014.04.043)